This statistic illustrates AstraZeneca's expenditure on research and development from 2006 to 2024. In 2024, AstraZeneca spent some 13.6 billion U.S. dollars on R&D. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Together with the Oxford University, the company also developed one of the first effective COVID-19 vaccines.
Research and development expenditure of AstraZeneca from 2006 to 2024
(in million U.S. dollars)
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Research and development expenditure of AstraZeneca from 2006 to 2024
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
AstraZeneca, & U.S. Securities and Exchange Commission. (February 17, 2025). Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 15, 2025, from https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, und U.S. Securities and Exchange Commission. "Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars)." Chart. February 17, 2025. Statista. Accessed April 15, 2025. https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, U.S. Securities and Exchange Commission. (2025). Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 15, 2025. https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, and U.S. Securities and Exchange Commission. "Research and Development Expenditure of Astrazeneca from 2006 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 17 Feb 2025, https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca & U.S. Securities and Exchange Commission, Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/ (last visited April 15, 2025)
Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars) [Graph], AstraZeneca, & U.S. Securities and Exchange Commission, February 17, 2025. [Online]. Available: https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
